Home › Swallowing Disorders › NCT07283653
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: 1. A hospital or clinic affiliated with the Veteran's Affairs system, University of Wisconsin system, or Ohio State University system. 2. A minimum average of 10 Modified Barium Swallow (MBS) procedures per month in oncology patients in preceding year. 3. MBS imaging files are recorded and archived as a routine procedure (and accessible to researchers). Exclusion Criteria: N/A
About the study
To improve swallowing outcomes in cancer through clinical implementation of the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST™) as an evidence-based practice (EBP) tool to grade pharyngeal dysphagia (difficulty swallowing) as a toxicity of cancer.
What is being tested
- No intervention (other)
- DIGEST Training Program (other)
- DIGEST Training + Practice Facilitation (other)
Sponsor: M.D. Anderson Cancer Center · Participants: 85 · Started: Jun 1, 2025
Contact the study team
- Kate Hutcheson, PHD · Phone: 713-792-6513
Official record on ClinicalTrials.gov — NCT07283653
Locations in the U.S.
| Texas | MD Anderson Cancer Center, Houston |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.